Recent breakthrough advances in machine learning and artificial intelligence may be instrumental in screening big databases in LIC and LMIC populations and building predicted disease risk analytics and better interventional roadmaps regarding the influence of APOE4 on neurodegenerative diseases in long COVID-19 patients. This evidence concerns the gene APOE and COVID-19.